Understanding how immune cells move and activate T cells
Programmed death ligand-1 interactions in the regulation of dendritic cell migration and T cell priming
This study is looking at how certain immune cells called dendritic cells move around in the body to help activate T cells, which are important for fighting off diseases like cancer, and it aims to find new ways to boost this process, especially when it comes to vaccines.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11003684 on NIH RePORTER |
What this research studies
This research investigates the role of dendritic cells in the immune system, focusing on how they migrate to lymph nodes to activate T cells. By examining the interactions between programmed death ligand-1 (PD-L1) and CD80 proteins, the study aims to uncover new ways to manipulate dendritic cell movement and enhance immune responses, particularly in vaccination contexts. The research employs advanced techniques like 2-photon microscopy to visualize these processes in real-time. The ultimate goal is to identify novel therapeutic targets that could improve immune responses against diseases such as cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from enhanced immune responses, such as cancer patients or those undergoing vaccination.
Not a fit: Patients with stable, non-immune related conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccination strategies and therapies that enhance the body's immune response against cancers and other diseases.
How similar studies have performed: Previous research has shown promising results in manipulating immune cell interactions, suggesting that this approach could yield significant advancements.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Kantheti, Uma — University of Colorado Denver
- Study coordinator: Kantheti, Uma
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.